Drugplain

Moxifloxacin ophthalmic solution 5 mg/mL

Moxifloxacin ophthalmic solution · SOLUTION/ DROPS · Alembic Pharmaceuticals Limited

No Recall HistoryCurrently in Shortage
Plain English

Moxifloxacin ophthalmic solution is a solution/ drops containing moxifloxacin ophthalmic solution at 5 mg/mL, taken ophthalmic. Manufactured by Alembic Pharmaceuticals Limited.

Key Facts

Brand Name
Moxifloxacin ophthalmic solution
Generic Name
Moxifloxacin ophthalmic solution
NDC Code (Product)
46708-505
Manufacturer
Alembic Pharmaceuticals Limited
Strength
5 mg/mL
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Marketing Status
Application #
ANDA209469
Marketing Start
02/13/2019

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

off label use2,157 reports
dyspnoea2,061 reports
asthma1,973 reports
drug ineffective1,950 reports
drug hypersensitivity1,940 reports
pneumonia1,877 reports
vomiting1,730 reports
pain1,596 reports
wheezing1,581 reports
rash1,492 reports

Frequently Asked Questions

What is Moxifloxacin ophthalmic solution used for?

Moxifloxacin ophthalmic solution contains Moxifloxacin ophthalmic solution. It is a solution/ drops taken ophthalmic. Consult your doctor for specific uses.

Is Moxifloxacin ophthalmic solution a controlled substance?

Moxifloxacin ophthalmic solution is not classified as a controlled substance by the DEA.

What is the generic name for Moxifloxacin ophthalmic solution?

The generic name for Moxifloxacin ophthalmic solution is Moxifloxacin ophthalmic solution. There are no other listed brand versions of Moxifloxacin ophthalmic solution.

What is the NDC code for Moxifloxacin ophthalmic solution 5 mg/mL?

The NDC (National Drug Code) for Moxifloxacin ophthalmic solution 5 mg/mL is 46708-505, listed by Alembic Pharmaceuticals Limited.

Product NDC

46708-505

Package NDC

46708-505-03

Other Moxifloxacin ophthalmic solution Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)